Alexander Daehne is a Principal Industry Consultant for SAS’ Global Health and Life Sciences Practice and provides thought leadership and expertise of deploying analytical solutions in quality, reliability and maintenance. He helps customers uncover value and achieve improved business outcomes from the Internet of Things. Additionally to Life Sciences, he is advising also manufacturing customers globally to understand their needs and providing solutions to achieve operational excellence. Before joining the Global Health and Life Sciences Practice he worked with SAS’ Global Manufacturing Practice and led the business development within the Manufacturing vertical at SAS EMEA/AP. Prior to working at SAS, Daehne lead the automotive team at Atos in Germany, bringing in over 25 years of experience in production, supply chain and service management.
The COVID-19 pandemic has revealed the vulnerability of pharmaceutical supply chains. Pharma companies are focusing on risk management to improve the resilience of their networks. Most of the measures they will take, including on-shoring, over capacities and redundancies, will lead to higher costs. To decrease inventory levels across these new
